Barbara Weber

Barbara L.
Weber was the founder of Tango Therapeutics, Inc., founded in 2017, and served as Executive Chairman in 2026.
Current jobs include President, Chief Executive Officer & Director at Tango Therapeutics Sub, Inc. since 2017; Independent Director at OPY Acquisition Corp.
I since 2021; Independent Director at Parabilis Medicines, Inc. since 2018; and Member of the American Society for Clinical Investigation and the American Association of Physician Specialists, Inc. Former jobs include Independent Director at Revolution Medicines, Inc. from 2018 to 2025; Director at the American Society of Clinical Oncology, Inc.; Director at the American Association for Cancer Research; Senior VP-Oncology Translational Medicine at Novartis AG from 2009 to 2015; Professor & Associate at the University of Pennsylvania from 1994 to 2005; Assistant Professor at the University of Michigan from 1988 to 1994; VP-Oncology Discovery & Translational Medicine at GlaxoSmithKline LLC from 2005 to 2009; Chief Medical Officer at BioNTech US, Inc. from 2015 to 2017; and Venture Partner at Third Rock Ventures LLC.
Education includes a doctorate from UW Medicine conferred in 1978 and an undergraduate degree from the University of Washington conferred in 1978.